Elder Pharmaceuticals Ltd. - Research Center
532322 ELDERPHARM Group (Z) BSE data
Results
|
Quarterly
|
Statement
|
|
More
|
|
Quarterly results in brief
(Rs crore)
|
Mar' 15 |
Dec' 14 |
Sep' 14 |
Jun' 14 |
Mar' 14 |
Sales |
24.39 |
35.55 |
203.14 |
90.75 |
101.73 |
Operating profit |
-22.82 |
-31.68 |
-25.58 |
-141.90 |
-13.48 |
Interest |
21.54 |
35.44 |
23.18 |
117.55 |
66.07 |
Gross profit |
-43.30 |
-66.41 |
-39.44 |
-263.35 |
-67.98 |
EPS (Rs) |
-24.93 |
-35.54 |
-22.82 |
53.09 |
-36.66 |
Quarterly
results in details
|
Mar' 15 |
Dec' 14 |
Sep' 14 |
Jun' 14 |
Mar' 14 |
Other income |
1.05 |
0.71 |
9.32 |
-3.89 |
11.58 |
Stock adjustment |
4.44 |
9.98 |
-3.02 |
110.04 |
-7.78 |
Raw material |
8.84 |
10.78 |
10.63 |
12.53 |
9.85 |
Power and fuel |
- |
- |
- |
- |
- |
Employee expenses |
11.92 |
15.14 |
44.91 |
34.07 |
30.39 |
Excise |
- |
- |
- |
- |
- |
Admin and selling expenses |
- |
- |
- |
- |
- |
Research and development expenses |
- |
- |
- |
- |
- |
Expenses capitalised |
- |
- |
- |
- |
- |
Other expenses |
22.01 |
31.34 |
176.20 |
76.01 |
82.74 |
Provisions made |
- |
- |
- |
- |
- |
Depreciation |
7.91 |
6.58 |
11.32 |
6.99 |
7.31 |
Taxation |
- |
- |
0.15 |
0.67 |
- |
Net profit / loss |
-51.21 |
-72.99 |
-46.87 |
109.03 |
-75.28 |
Extra ordinary item |
- |
- |
4.03 |
380.04 |
- |
Prior year adjustments |
- |
- |
- |
- |
- |
Equity capital |
20.54 |
20.54 |
20.54 |
20.54 |
20.54 |
Equity dividend rate |
- |
- |
- |
- |
- |
Agg.of non-prom. shares (Lacs) |
153.55 |
- |
148.12 |
153.49 |
154.39 |
Agg.of non promotoholding (%) |
74.77 |
- |
72.12 |
74.74 |
75.17 |
OPM (%) |
-93.56 |
-89.09 |
-12.59 |
-156.37 |
-13.25 |
GPM (%) |
-170.22 |
-183.15 |
-18.56 |
-303.20 |
-60.00 |
NPM (%) |
-201.30 |
-201.28 |
-22.06 |
125.53 |
-66.44 |